Molecular Cancer (Jul 2022)
Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
- Heng Li,
- Gan Yu,
- Runlin Shi,
- Bin Lang,
- Xianguo Chen,
- Ding Xia,
- Haibing Xiao,
- Xiaolin Guo,
- Wei Guan,
- Zhangqun Ye,
- Wei Xiao,
- Hua Xu
Affiliations
- Heng Li
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Gan Yu
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Runlin Shi
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Bin Lang
- School of Health Sciences, Macao Polytechnic Institute
- Xianguo Chen
- Department of Urology, First Affiliated Hospital of Anhui Medical University
- Ding Xia
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Haibing Xiao
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Xiaolin Guo
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Wei Guan
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Zhangqun Ye
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Wei Xiao
- Translational Medicin Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Hua Xu
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- DOI
- https://doi.org/10.1186/s12943-022-01614-9
- Journal volume & issue
-
Vol. 21,
no. 1
pp. 1 – 3
Abstract
No abstracts available.
